RXi Pharmaceuticals Corp 4
4 · RXi Pharmaceuticals Corp · Filed Feb 3, 2017
Insider Transaction Report
Form 4
Pavco Pamela
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2017-02-01+7,000→ 7,000 totalExercise: $0.63Exp: 2027-02-01→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.